EBM 3/18 Autumn

Page 1

ISSN 2364-2351 | A 60711 |

Life Sciences and Industry Magazine Autumn Edition 2018 | Volume 17 | 20 €

Interview Novozymes’s New Business Development Head Sebastian Søderberg on the value of open innovation.

T cell therapies

CARs crash cancer Modern breeding How the ECJ ruling on genome editing thwarts organic farming

01_EB_Autumn_2018_Title_tg.indd 1

DNA synthesis

Can a new enzyme approach help solve global problems?

Photosynthesis

CROs & CDMOs

Engineers converge on the Holy Grail of energy production

New technologies that trigger pharma outsourcing growth

20.09.2018 14:45:26 Uhr


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
EBM 3/18 Autumn by BIOCOM Interrelations GmbH - Issuu